FDA expands access to a promising drug for one of the worst cancers The Washington PostF.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer The New York TimesFDA green lights early access to pancreatic cancer drug, daraxonrasib USA TodayUS FDA authorizes early access to Revolution's pancreatic cancer pill Yahoo
